Among HIV-infected adults attending non-governmental organization voluntary counseling and testing (VCT) sites in Uganda that provide a nine-month course of isoniazid preventive treatment (IPT), we report on loss to follow-up (LTFU) and its associated risk factors. The design was a retrospective cohort study of program data spanning a three year period (2006-2008). A total of 586 IPT patients were enrolled of whom 335 (57.1%) were females with a mean age of 34 years. Of those starting IPT, 341 (58.1%) were lost to follow-up, 197 (33.6%) completed IPT, 29 (4.9%) were discontinued and 19 (3.2%) died. The return rates at one, three, five and seven months were 78.0% (457), 62.1% (364), 52.9% (310) and 33.6% (197) respectively. Being less than 3...
OBJECTIVE The retention of patients on antiretroviral therapy (ART) is key to achieving global ta...
INTRODUCTION:Loss to follow up after the initiation of antiretroviral therapy (ART) is common in Afr...
Shegaw Zeleke,1 Solomon Demis,2 Yeshiambaw Eshetie,1 Demewoz Kefale,3 Yohannes Tesfahun,4 Tigabu Mun...
Background: The purpose of this case–control study was to identify risk factors for loss to follow-u...
Background: Tuberculosis (TB) is the leading cause of death in persons living with HIV (PLHIV). PLHI...
OBJECTIVES—We assessed retention and predictors of attrition (recorded death or loss to follow-up) i...
BackgroundIsoniazid preventive therapy (IPT) is given to HIV patients to reduce the risk of active t...
BACKGROUND:Retaining patients starting antiretroviral therapy (ART) and ensuring good adherence rema...
SETTING: Despite worldwide scale-up of human immunodeficiency virus (HIV) care services, relatively ...
Setting: Seven pilot sites in Zimbabwe implementing 6 months of isoniazid preventive therapy (IPT) f...
Rates of Isoniazid Preventive Therapy (IPT) completion remain low in programmatic settings in sub-Sa...
Scaling up of Antiretroviral (ARV) drugs is crucial and should be a perpetual venture in developing ...
OBJECTIVES: To understand reasons for lost to follow-up (LTFU) from a community-based antiretroviral...
SETTING: Despite worldwide scale-up of human immunodeficiency virus (HIV) care services, relativel...
Abstract Objective This study was aimed at assessing the incidence of lost-to-follow-up and its pred...
OBJECTIVE The retention of patients on antiretroviral therapy (ART) is key to achieving global ta...
INTRODUCTION:Loss to follow up after the initiation of antiretroviral therapy (ART) is common in Afr...
Shegaw Zeleke,1 Solomon Demis,2 Yeshiambaw Eshetie,1 Demewoz Kefale,3 Yohannes Tesfahun,4 Tigabu Mun...
Background: The purpose of this case–control study was to identify risk factors for loss to follow-u...
Background: Tuberculosis (TB) is the leading cause of death in persons living with HIV (PLHIV). PLHI...
OBJECTIVES—We assessed retention and predictors of attrition (recorded death or loss to follow-up) i...
BackgroundIsoniazid preventive therapy (IPT) is given to HIV patients to reduce the risk of active t...
BACKGROUND:Retaining patients starting antiretroviral therapy (ART) and ensuring good adherence rema...
SETTING: Despite worldwide scale-up of human immunodeficiency virus (HIV) care services, relatively ...
Setting: Seven pilot sites in Zimbabwe implementing 6 months of isoniazid preventive therapy (IPT) f...
Rates of Isoniazid Preventive Therapy (IPT) completion remain low in programmatic settings in sub-Sa...
Scaling up of Antiretroviral (ARV) drugs is crucial and should be a perpetual venture in developing ...
OBJECTIVES: To understand reasons for lost to follow-up (LTFU) from a community-based antiretroviral...
SETTING: Despite worldwide scale-up of human immunodeficiency virus (HIV) care services, relativel...
Abstract Objective This study was aimed at assessing the incidence of lost-to-follow-up and its pred...
OBJECTIVE The retention of patients on antiretroviral therapy (ART) is key to achieving global ta...
INTRODUCTION:Loss to follow up after the initiation of antiretroviral therapy (ART) is common in Afr...
Shegaw Zeleke,1 Solomon Demis,2 Yeshiambaw Eshetie,1 Demewoz Kefale,3 Yohannes Tesfahun,4 Tigabu Mun...